Suppr超能文献

接受新鲜冰冻血浆输注患者的结局:日本广岛一项前瞻性、观察性、多中心队列研究

Outcomes of Patients Who Undergo Transfusion of Fresh Frozen Plasma: A Prospective, Observational, Multicentre Cohort Study in Hiroshima, Japan.

作者信息

Sugiyama Aya, Fujii Teruhisa, Okikawa Yoshiko, Sasaki Fumie, Okajima Masazumi, Hidaka Hidekuni, Iwato Koji, Sato Kazuyoshi, Kokubunji Akira, Takata Noboru, Yamamoto Masahiro, Tanaka Junko

机构信息

Department of Epidemiology, Infectious Disease Control and Prevention, Graduate School of Biomedical and Health Sciences, Hiroshima University, Hiroshima, Japan.

Division of Transfusion Medicine, Hiroshima University Hospital, Hiroshima, Japan.

出版信息

J Blood Med. 2021 Nov 12;12:965-973. doi: 10.2147/JBM.S338556. eCollection 2021.

Abstract

PURPOSE

Given the chronic shortage of blood for transfusion in Japan, promotion of appropriate use of fresh frozen plasma (FFP) urgently needs to be addressed by the national blood project in Japan. Whether FFP transfusions are administered appropriately in Japan is currently unclear. In this study, we aimed to investigate the outcomes of patients who undergo FFP transfusion and the appropriateness of use of FFP.

PATIENTS AND METHODS

This multicentre, prospective, observational cohort study was conducted from September 2017 to April 2019 at the 15 medical institutions in Hiroshima Prefecture that are the top providers of FFP. All patients who underwent FFP transfusion during the study period were included, relevant data being extracted from the medical records. The indications for FFP transfusion were classified in accordance with the Guidelines of the Ministry of Health, Labour and Welfare of Japan. Factors associated with patient outcomes at day 28 after FFP transfusion were subjected to multivariable logistic regression analysis.

RESULTS

In total, data of 1299 patients were eligible for analysis. At least 63.8% of indications for FFP were in accordance with the guideline for FFP transfusions. The mortality rate at day 28 after FFP transfusion was 16.2%. Older age (65-74 years: adjusted odds ratio [AOR]=4.3, ≥75 years: AOR=4.1), non-perioperative use (AOR=4.5), coagulopathy associated with liver damage (AOR=2.7), large volume of FFP transfused (AOR=2.5), and lack of improvement in blood coagulation following FFP transfusion were independently and significantly associated with death within 28 days after FFP transfusion.

CONCLUSION

Our findings do not support the simple conclusion that FFP transfusions contribute to prognosis. However, given that coagulopathy in patients with end-stage liver disease is infrequently improved by FFP transfusion, "inappropriate" use of FFP should be avoided. It is important to promote appropriate use of FFP so as not to waste blood resources.

摘要

目的

鉴于日本长期存在输血用血短缺的问题,日本国家血液项目迫切需要解决促进新鲜冰冻血浆(FFP)合理使用的问题。目前尚不清楚FFP输血在日本是否得到合理应用。在本研究中,我们旨在调查接受FFP输血患者的结局以及FFP使用的合理性。

患者与方法

本多中心、前瞻性、观察性队列研究于2017年9月至2019年4月在广岛县15家FFP供应最多的医疗机构进行。纳入研究期间所有接受FFP输血的患者,从病历中提取相关数据。FFP输血的适应证按照日本厚生劳动省的指南进行分类。对FFP输血后第28天与患者结局相关的因素进行多变量逻辑回归分析。

结果

共有1299例患者的数据符合分析要求。至少63.8%的FFP适应证符合FFP输血指南。FFP输血后第28天的死亡率为16.2%。年龄较大(65 - 74岁:调整优势比[AOR]=4.3,≥75岁:AOR=4.1)、非围手术期使用(AOR=4.5)、与肝损伤相关的凝血病(AOR=2.7)、大量输注FFP(AOR=2.5)以及FFP输血后凝血功能未改善与FFP输血后28天内死亡独立且显著相关。

结论

我们的研究结果不支持FFP输血有助于改善预后这一简单结论。然而,鉴于终末期肝病患者的凝血病很少能通过FFP输血得到改善,应避免“不适当”使用FFP。促进FFP的合理使用以避免浪费血液资源很重要。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/333a/8594890/e8cf5fbe7689/JBM-12-965-g0001.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验